Vanguard Group’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $7.04M | Sell |
880,049
-154,801
| -15% | -$1.24M | ﹤0.01% | 3084 |
|
2025
Q1 | $10.1M | Buy |
1,034,850
+667,181
| +181% | +$6.51M | ﹤0.01% | 2840 |
|
2024
Q4 | $4.65M | Sell |
367,669
-26,832
| -7% | -$339K | ﹤0.01% | 3302 |
|
2024
Q3 | $6.34M | Buy |
394,501
+5,967
| +2% | +$95.9K | ﹤0.01% | 3168 |
|
2024
Q2 | $9.48M | Buy |
388,534
+76,928
| +25% | +$1.88M | ﹤0.01% | 2964 |
|
2024
Q1 | $22.4M | Buy |
311,606
+54,578
| +21% | +$3.92M | ﹤0.01% | 2547 |
|
2023
Q4 | $51.1M | Buy |
257,028
+4,115
| +2% | +$818K | ﹤0.01% | 2181 |
|
2023
Q3 | $33.6M | Buy |
252,913
+9,544
| +4% | +$1.27M | ﹤0.01% | 2318 |
|
2023
Q2 | $36.4M | Buy |
243,369
+45,679
| +23% | +$6.83M | ﹤0.01% | 2332 |
|
2023
Q1 | $29M | Buy |
197,690
+9,293
| +5% | +$1.36M | ﹤0.01% | 2430 |
|
2022
Q4 | $29.8M | Buy |
188,397
+27,908
| +17% | +$4.42M | ﹤0.01% | 2431 |
|
2022
Q3 | $30.9M | Buy |
160,489
+2,296
| +1% | +$442K | ﹤0.01% | 2420 |
|
2022
Q2 | $23.1M | Buy |
158,193
+5,125
| +3% | +$748K | ﹤0.01% | 2571 |
|
2022
Q1 | $26.9M | Buy |
153,068
+2,274
| +2% | +$400K | ﹤0.01% | 2616 |
|
2021
Q4 | $44.3M | Buy |
150,794
+15,933
| +12% | +$4.68M | ﹤0.01% | 2419 |
|
2021
Q3 | $33.5M | Buy |
134,861
+20,621
| +18% | +$5.12M | ﹤0.01% | 2585 |
|
2021
Q2 | $29.1M | Buy |
114,240
+20,315
| +22% | +$5.17M | ﹤0.01% | 2643 |
|
2021
Q1 | $16.7M | Buy |
93,925
+2,276
| +2% | +$404K | ﹤0.01% | 2881 |
|
2020
Q4 | $14.5M | Buy |
91,649
+18,521
| +25% | +$2.93M | ﹤0.01% | 2801 |
|
2020
Q3 | $18.8M | Buy |
73,128
+15,983
| +28% | +$4.12M | ﹤0.01% | 2487 |
|
2020
Q2 | $13.3M | Buy |
57,145
+22,111
| +63% | +$5.13M | ﹤0.01% | 2626 |
|
2020
Q1 | $5.96M | Buy |
35,034
+17,069
| +95% | +$2.9M | ﹤0.01% | 2891 |
|
2019
Q4 | $3.97M | Buy |
+17,965
| New | +$3.97M | ﹤0.01% | 3244 |
|